 |
|
|
| Section |
Building No (Floor) |
| DIRECTOR GENERAL |
11(2F) |
| DEPUTY DIRECTOR GENERAL |
11(2F) |
| DIVISION OF GENERAL AFFAIRS |
11(1F)* |
| PLANNING AND COORDINATION |
|
| DIVISION OF DRUGS |
11(2F)* |
| DIVISION OF BIOLOGICAL CHEMISTRY BIOLOGICALS |
11(2F)* |
| DIVISION OF PHARMACOGNOSY, PHYTOCHEMISTRY AND NARCOTICS |
2(3F)*,11(2F) |
| DIVISION OF CELLULAR AND GENE THERAPY PRODUCTS |
2(1F)*,4(2F),28(2F) |
| DIVISION OF MEDICAL DEVICES |
11(3F)* |
| DIVISION OF ENVIRONMENTAL
CHEMISTRY |
2(3F),3(2F),10(2F)* |
| DIVISION OF FOODS |
2(2F)*,2(3F) |
| DIVISION OF FOOD ADDITIVES |
2(2F)* |
| DIVISION OF BIOMEDICAL FOOD RESEARCH |
28(1F),28(2F)* |
| DIVISION OF MICROBIOLOGY |
2(1F),28(1F)*,28(2F) |
| DIVISION OF ORGANIC
CHEMISTRY |
2(1F)* |
| DIVISION OF BIOCHEMISTRY AND IMMUNOCHEMISTRY |
11(1F)* |
| DIVISION OF BIOSIGNALING |
11(1F)*,11(3F) |
| DIVISION OF SAFETY INFORMATION ON DRUG, FOOD AND CHEMICALS |
11(3F),14(12F)*,28(3F) |
| DIVISION OF MEDICINAL SAFETY SCIENCE |
28(3F)* |
| HEAD OF BIOLOGICAL SAFETY RESEARCH CENTER |
8(2F) |
| DIVISION OF CELLULAR AND MOLECULAR TOXICOLOGY |
8(2F),8(3F),8(4F)* |
| DIVISION OF PHARMACOLOGY |
4(2F)*,4(3F),10(2F) |
| DIVISION OF PATHOLOGY |
8(2F)*,8(3F) |
| DIVISION OF GENETICS AND MUTAGENESIS |
8(3F)*,10(2F) |
| DIVISION OF RISK ASSESSMENT |
28(3F)* |
|
|
|
|
|
|
COPYRIGHT (C) 2006 National Institute of Health Sciences ALL RIGHTS RESERVED.
